Time to stop reporting estimates of any prostate cancer risk with percentage of free prostate-specific antigen

被引：1
作者：
Ho, Matthew D. [1 ]
Yeo, Kiang-Teck J. [2 ]
Eggener, Scott E. [1 ]
机构：
[1] Univ Chicago, Dept Surg, Sect Urol, Chicago, IL 60637 USA
[2] Univ Chicago, Dept Pathol, Sect Clin Chem, Chicago, IL USA
来源：
AMERICAN JOURNAL OF CLINICAL PATHOLOGY | 2024年 / 161卷 / 01期
关键词：
free; prostate; specific; antigen; cancer; PSA; overtreatment; overdiagnosis; risk;
D O I：
10.1093/ajcp/aqad109
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
引用
收藏
页码：1 / 3
页数：3
相关论文
共 50 条
[31]   Prostate-specific antigen vs prostate-specific antigen density as a predictor of upgrading in men diagnosed with Gleason 6 prostate cancer by contemporary multicore prostate biopsy [J].
Oh, Jong Jin ;
Hong, Sung Kyu ;
Lee, Jung Keun ;
Lee, Byung Ki ;
Lee, Sangchul ;
Kwon, Oh Sung ;
Byun, Seok-Soo ;
Lee, Sang Eun .
BJU INTERNATIONAL, 2012, 110 (11B) :E494-E499
[32]   Is free prostate-specific antigen helpful in the differential diagnosis of benign hyperplasia and cancer of the prostate? [J].
Reiter, W ;
Stieber, P ;
Schmeller, N ;
Nagel, D ;
Schambeck, C ;
FatehMoghadam, A .
TUMOR BIOLOGY, 1997, 18 (02) :80-87
[33]   SERUM-FREE PROSTATE-SPECIFIC ANTIGEN - ISOENZYMES IN BENIGN HYPERPLASIA AND CANCER OF THE PROSTATE [J].
HUBER, PR ;
SCHMID, HP ;
MATTARELLI, G ;
STRITTMATTER, B ;
VANSTEENBRUGGE, GJ ;
MAURER, A .
PROSTATE, 1995, 27 (04) :212-219
[34]   Real-time prostate-specific antigen detection with prostate-specific antigen imprinted capacitive biosensors [J].
Erturk, Gizem ;
Hedstrom, Martin ;
Tumer, M. Askin ;
Denizli, Adil ;
Mattiasson, Bo .
ANALYTICA CHIMICA ACTA, 2015, 891 :120-129
[35]   Percent free prostate-specific antigen does not improve the effectiveness of prostate cancer detection in Chinese men with a prostate-specific antigen of 2.5-20.0 ng/ml: a multicenter study [J].
Huang, Maping ;
Lin, Yurong ;
Xu, Abai ;
Uhlman, Matthew ;
Deng, Xiangrong ;
Lin, Xuanting ;
Wu, Sifeng ;
Diao, Pengfei ;
Xie, Keji ;
Tang, Ping .
MEDICAL ONCOLOGY, 2014, 31 (04)
[36]   Tumor Volume, Tumor Percentage Involvement, or Prostate Volume: Which Is Predictive of Prostate-specific Antigen Recurrence? [J].
Uhlman, Matthew A. ;
Sun, Leon ;
Stackhouse, Danielle A. ;
Caire, Arthur A. ;
Polascik, Thomas J. ;
Robertson, Cary N. ;
Madden, John ;
Vollmer, Robin ;
Albala, David M. ;
Moul, Judd W. .
UROLOGY, 2010, 75 (02) :460-466
[37]   The stability of free and bound prostate-specific antigen [J].
Cartledge, JJ ;
Thompson, D ;
Verril, H ;
Clarkson, P ;
Eardley, I .
BJU INTERNATIONAL, 1999, 84 (07) :810-814
[38]   Evaluation of the serum testosterone to prostate-specific antigen ratio as a predictor of prostate cancer risk [J].
Morote, Juan ;
Planas, Jacques ;
Ramirez, Cristobal ;
Gomez, Esther ;
Raventos, Carles X. ;
Placer, Jose ;
Catalan, Roberto ;
de Torres, Ines M. .
BJU INTERNATIONAL, 2010, 105 (04) :481-484
[39]   Association between prostate-specific antigen change over time and prostate cancer recurrence risk: A joint model [J].
Mohammadpour, Reza Ali ;
Alizadeh, Ahad ;
Barzegar, Mohammad-Reza ;
Pasha, Abazar Akbarzadeh .
CASPIAN JOURNAL OF INTERNAL MEDICINE, 2020, 11 (03) :324-328
[40]   A Risk-Based Strategy Improves Prostate-Specific Antigen-Driven Detection of Prostate Cancer [J].
Roobol, Monique J. ;
Steyerberg, Ewout W. ;
Kranse, Ries ;
Wolters, Tineke ;
van den Bergh, Roderick C. N. ;
Bangma, Chris H. ;
Schroeder, Fritz H. .
EUROPEAN UROLOGY, 2010, 57 (01) :79-85
12345